Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 4—April 2002

Research

Outcomes of Treated Human Granulocytic Ehrlichiosis Cases

Alan H. Ramsey*†Comments to Author , Edward A. Belongia‡, Craig M. Gale‡, and Jeffrey P. Davis†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Wisconsin Division of Public Health, Madison, Wisconsin, USA; ‡Marshfield Medical Research Foundation, Marshfield, Wisconsin, USA;

Main Article

Table 1

Recurrent or continuous symptoms experienced during the preceding 12 months by human granulocytic ehrlichiosis patients and controls, Wisconsin, 1999

Symptom Patients (N=85)
number (%) Controls
(N=102)
number (%) OR 95% CI
Fevers 12 (14.1) 3 (2.9) 5.4 1.7-24.4
Shaking chills 16 (18.8) 5 (4.9) 4.5 1.7-14.3
Sweats 31 (36.5) 16 (15.7) 3.1 1.6-6.3
Fatigue 47 (55.3) 38 (37.3) 2.1 1.2-3.7
Confusion 16 (18.8) 12 (11.8) 1.7 0.8-4.0
Muscle weakness 27 (31.8) 30 (29.4) 1.1 0.6-2.1
Headache 21 (24.7) 13 (12.8) 1.1 0.7-1.9
Muscle aches 40 (47.1) 44 (43.1) 1.0 0.7-1.5
Joint pains 50 (58.8) 54 (52.9) 0.9 0.6-1.2
Nausea 14 (16.5) 15 (14.7) 0.8 0.5-1.4

OR = odds ratio; 95% CI = 95% confidence interval.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO